Everest Organics Limited

BSE: 524790
Everest Organics Limited - pharma in Medak, Telangana, India. FY 2026 financials and compliance.
CIN L24230TG1993PLC015426 Incorporated 19 February 1993 ROC Hyderabad HQ Medak, Telangana, India
Active Listed - BSE: 524790 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹196.16 Cr
▲ 23% YoY
Computed EBITDA · FY 2026
₹21.06 Cr
▲ 166.22% YoY
Net profit · FY 2026
₹5.55 Cr
▲ 529.86% YoY
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.71 Cr
Issued & subscribed
Open charges
₹73.38 Cr
Satisfied ₹118.08 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
387
Latest available

About Everest Organics Limited

Data last updated: 09 December 2025

Everest Organics Limited is a public limited company based in Medak, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 19 February 1993, the company has been in operation for over 33 years.

Registered with ROC Hyderabad under CIN L24230TG1993PLC015426. Listed on BSE: 524790.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.71 Cr. It is led by directors including Hari Krishna Srikakarlapudi and Srikakarlapudi Sirisha.

Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2025. Office: Aroor Village Sadasivapet Mandal Medak, Telangana, India – 502291.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹196.16 Cr, a growth of 23% compared to the previous year. The net worth stands at ₹75.48 Cr (up 7.91% YoY). Total assets are valued at ₹239.8 Cr (up 6.82% YoY).

The company has a workforce of approximately 387 employees as per the latest available data.

The company is associated with 1 brand - Everest Organics. As per MCA filings, the company has open charges of ₹73.38 Cr and satisfied charges of ₹118.08 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website everestorganicsltd.com.

Company Details of Everest Organics Limited
CIN L24230TG1993PLC015426
Registration Number 015426
Incorporation Date 19 February 1993
ROC Hyderabad
Listing Status Listed (BSE: 524790)
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Srikakarlapudi Sirisha Managing Director Hari Krishna Srikakarlapudi Whole-Time Director Kirankumar Rampally Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    everestorganicsltd.com
  • Social Media
  • Registered Address
    Aroor Village Sadasivapet Mandal Medak, Telangana, India – 502291
  • Industry
    Pharma, API Manufacturers
Company report
Everest Organics Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Everest Organics Limited report

Financials, compliance, directors, charges, ownership and filings for Everest Organics Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Everest Organics Limited

Everest Organics Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24230TG1993PLC015426, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24230TG1993PLC015426 Current
L24230AP1993PLC015426 Previous
U24230AP1993PLC015426 Previous

Associated Brands with Everest Organics Limited

Everest Organics Limited operates one associated brand: Everest Organics. These brands represent Everest Organics Limited's diversified market presence and brand portfolio.

Brand Description Website
Everest Organics
APIs and pharmaceutical intermediates are manufactured by Everest Organics. everestorganicsltd.com

Competitors & Alternatives of Everest Organics Limited

Brands and companies operating in the same space as Everest Organics Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Everest Organics Limited

Everest Organics Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Everest Organics Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Everest Organics Limited

Everest Organics Limited is audited by PSN RAVISHANKER & ASSOCIATES (ICAI peer reviewed, certificate valid till 2019-01-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
PSN RAVISHANKER & ASSOCIATES (ICAI peer reviewed, certificate valid till 2019-01-31) FY 2026 Statement on impact of audit qualification

Board of Directors of Everest Organics Limited

Everest Organics Limited is currently managed by 5 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Hari Krishna Srikakarlapudi
Also directs: Everest Organics Limited
Whole-Time Director 29 Sep 2007 18 Years 9 Months Current
Srikakarlapudi Sirisha
Also directs: Everest Organics Limited, Everest Life Sciences Private Limited
Managing Director 30 Jul 2014 11 Years 11 Months Current
Kirankumar Rampally
Also directs: Everest Organics Limited, Photon Life Sciences Llp
Director 13 Jan 2025 1 Years 6 Months Current
Venkata Satyanarayana Murthy Vadali
Also directs: Everest Organics Limited
Director 13 Nov 2024 1 Years 8 Months Current
Prasad Venkata Satya Sundara Srikakolapu
Also directs: Everest Organics Limited
Director 01 Sep 2023 2 Years 10 Months Current
View all directors

Financials of Everest Organics Limited FY 2026 filings available

Everest Organics Limited reported revenue of ₹196.16 Cr (up 23% YoY) for FY 2026.

Revenue · FY 2026
₹196.16 Cr ▲ 23%
Profit · FY 2026
₹5.55 Cr ▲ 529.86%
Computed EBITDA · FY 2026
₹21.06 Cr ▲ 166.22%
Revenue₹ Cr · Standalone0100200300FY 2019: ₹156 Cr156FY 2019FY 2020: ₹167 Cr · +7.3% YoY167+7.3%FY 2020FY 2021: ₹182 Cr · +8.6% YoY182+8.6%FY 2021FY 2022: ₹200 Cr · +10.2% YoY200+10.2%FY 2022FY 2023: ₹183 Cr · -8.5% YoY183-8.5%FY 2023FY 2024: ₹197 Cr · +7.8% YoY197+7.8%FY 2024FY 2025: ₹159 Cr · -19.1% YoY159-19.1%FY 2025FY 2026: ₹196 Cr · +23% YoY196+23%FY 2026
Net Profit₹ Cr · Standalone-5051015FY 2019: ₹8 Cr7.5FY 2019FY 2020: ₹11 Cr · +45.1% YoY10.9+45.1%FY 2020FY 2021: ₹14 Cr · +25.9% YoY13.7+25.9%FY 2021FY 2022: ₹1 Cr · -91.7% YoY1.1-91.7%FY 2022FY 2023: ₹0 Cr (loss) · -115.9% YoY-0.2FY 2023FY 2024: ₹0 Cr · +176.4% YoY0.1+176.4%FY 2024FY 2025: ₹1 Cr (loss) · -1026.9% YoY-1.3FY 2025FY 2026: ₹6 Cr · +529.9% YoY5.5+529.9%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0204060Q1'25: ₹32 Cr32.4Q1'25Q2'25: ₹44 Cr44Q2'25Q3'25: ₹42 Cr42.1Q3'25Q4'25: ₹41 Cr40.9Q4'25Q1'26: ₹54 Cr · +65.9% YoY53.8+65.9%Q1'26Q2'26: ₹51 Cr · +15.8% YoY51+15.8%Q2'26Q3'26: ₹43 Cr · +1.3% YoY42.6+1.3%Q3'26Q4'26: ₹49 Cr · +19.1% YoY48.7+19.1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹196.16 Cr ₹159.48 Cr ₹197.24 Cr ₹183.05 Cr ₹200.05 Cr ₹181.57 Cr ₹167.21 Cr ₹155.85 Cr
Other Income ₹1.25 Cr ₹68.69 Lakh ₹88.61 Lakh ₹6.94 Cr ₹2.21 Cr ₹1.06 Cr ₹1.45 Cr ₹54.35 Lakh
Total Income ₹197.4 Cr ₹160.17 Cr ₹198.13 Cr ₹189.99 Cr ₹202.26 Cr ₹182.63 Cr ₹168.67 Cr ₹156.39 Cr
Cost of Materials Consumed ₹125.31 Cr ₹97.5 Cr ₹123.41 Cr ₹124.9 Cr ₹140.36 Cr ₹115.99 Cr ₹102.26 Cr ₹95.72 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹1.95 Cr ₹1.04 Cr ₹55.9 Lakh -₹3.23 Cr -₹4.51 Cr -₹8.22 Cr -₹5.78 Cr -₹2.15 Cr
Employee Benefit Expense ₹15.48 Cr ₹16.35 Cr ₹18.8 Cr ₹16.3 Cr ₹16.33 Cr ₹15.26 Cr ₹13.3 Cr ₹11.64 Cr
Finance Costs ₹6.53 Cr ₹5.19 Cr ₹5.47 Cr ₹3.31 Cr ₹3.1 Cr ₹3.26 Cr ₹3.32 Cr ₹3.21 Cr
Depreciation & Amortisation ₹6.48 Cr ₹5.96 Cr ₹5.8 Cr ₹4.47 Cr ₹3.8 Cr ₹3.37 Cr ₹3.21 Cr ₹2.84 Cr
Other Expenses ₹37.5 Cr ₹37.36 Cr ₹43.48 Cr ₹44.15 Cr ₹41.45 Cr ₹35.69 Cr ₹38.26 Cr ₹32.81 Cr
Total Expenses ₹189.36 Cr ₹163.41 Cr ₹197.52 Cr ₹189.9 Cr ₹200.52 Cr ₹165.35 Cr ₹154.57 Cr ₹144.07 Cr
Profit Before Exceptional Items & Tax ₹8.05 Cr -₹3.24 Cr ₹61.04 Lakh ₹8.99 Lakh ₹1.74 Cr ₹17.27 Cr ₹14.09 Cr ₹12.33 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹8.05 Cr -₹3.24 Cr ₹61.04 Lakh ₹8.99 Lakh ₹1.74 Cr ₹17.27 Cr ₹14.09 Cr ₹12.33 Cr
Total Tax Expense ₹2.5 Cr -₹1.95 Cr ₹47.12 Lakh ₹27.21 Lakh ₹59.56 Lakh ₹3.56 Cr ₹3.2 Cr ₹4.82 Cr
Net Profit ₹5.55 Cr -₹1.29 Cr ₹13.92 Lakh -₹18.22 Lakh ₹1.14 Cr ₹13.72 Cr ₹10.9 Cr ₹7.51 Cr
Other Comprehensive Income -₹1.52 Lakh -₹1.6 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹5.53 Cr -₹2.89 Cr ₹13.92 Lakh -₹18.22 Lakh ₹1.14 Cr ₹13.72 Cr ₹10.9 Cr ₹7.51 Cr
EBITDA (computed) ₹21.06 Cr ₹7.91 Cr ₹11.87 Cr ₹7.87 Cr ₹8.64 Cr ₹23.9 Cr ₹20.62 Cr ₹18.38 Cr
Basic EPS ₹5.70 ₹-2.97 ₹0.17 ₹-0.23 ₹1.43 ₹17.14 ₹13.62 ₹9.39
Diluted EPS ₹5.70 ₹-2.97 ₹0.17 ₹-0.23 ₹1.43 ₹17.14 ₹13.62 ₹9.39
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹239.8 Cr ₹224.48 Cr ₹226.72 Cr ₹201.85 Cr ₹178 Cr ₹135.38 Lakh Cr ₹120.29 Lakh Cr ₹107.28 Lakh Cr
Non-current Assets ₹72.37 Cr ₹76.58 Cr ₹76.74 Cr ₹69.37 Cr ₹60.12 Cr ₹46.13 Lakh Cr ₹41.16 Lakh Cr ₹40.43 Lakh Cr
Current Assets ₹167.43 Cr ₹147.9 Cr ₹149.98 Cr ₹132.48 Cr ₹117.88 Cr ₹89.25 Lakh Cr ₹79.14 Lakh Cr ₹66.85 Lakh Cr
Property, Plant & Equipment ₹43.9 Cr ₹48.34 Cr ₹52.33 Cr ₹54.47 Cr ₹48.97 Cr ₹43.57 Lakh Cr ₹39.04 Lakh Cr ₹38.5 Lakh Cr
Inventories ₹44.81 Cr ₹45.25 Cr ₹43.76 Cr ₹46.74 Cr ₹41.49 Cr ₹32.92 Lakh Cr ₹27.4 Lakh Cr ₹18.45 Lakh Cr
Trade Receivables ₹116.16 Cr ₹88.43 Cr ₹100.09 Cr ₹76.33 Cr ₹68.57 Cr ₹50.62 Lakh Cr ₹44.3 Lakh Cr ₹40.71 Lakh Cr
Cash & Equivalents ₹10.17 Lakh ₹6.09 Cr ₹27.34 Lakh ₹82.88 Lakh ₹65.15 Lakh ₹166,171 Cr ₹200,123 Cr ₹196,159 Cr
Equity (Net Worth) ₹75.48 Cr ₹69.95 Cr ₹45.84 Cr ₹46.21 Cr ₹46.8 Cr ₹46.58 Lakh Cr ₹34.2 Lakh Cr ₹25.98 Lakh Cr
Equity Share Capital ₹9.71 Cr ₹9.71 Cr ₹8 Cr ₹8 Cr ₹8 Cr ₹800,000 Cr ₹800,000 Cr ₹800,000 Cr
Borrowings (Non-current) ₹7.28 Cr ₹9.2 Cr ₹14.64 Cr ₹11.65 Cr ₹10.99 Cr ₹581,443 Cr ₹461,253 Cr ₹483,329 Cr
Borrowings (Current) ₹42.66 Cr ₹38.68 Cr ₹43.15 Cr ₹39.4 Cr ₹27.79 Cr ₹14.11 Lakh Cr ₹10.57 Lakh Cr ₹14 Lakh Cr
Total Debt (computed) ₹49.93 Cr ₹47.87 Cr ₹57.79 Cr ₹51.05 Cr ₹38.78 Cr ₹19.92 Lakh Cr ₹15.19 Lakh Cr ₹18.83 Lakh Cr
Current Liabilities ₹152.2 Cr ₹139.92 Cr ₹160.1 Cr ₹137.58 Cr ₹112.56 Cr ₹77.36 Lakh Cr ₹74.01 Lakh Cr ₹70.93 Lakh Cr
Total Liabilities ₹164.32 Cr ₹154.54 Cr ₹180.88 Cr ₹155.63 Cr ₹131.2 Cr ₹88.8 Lakh Cr ₹86.09 Lakh Cr ₹81.3 Lakh Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹4.18 Cr -₹5.38 Cr ₹15.04 Cr -₹24.88 Cr ₹20.59 Cr
Investing Cash Flow -₹1.72 Cr -₹5.17 Cr -₹13.32 Cr ₹13.53 Cr -₹17.7 Cr
Financing Cash Flow -₹8.45 Cr ₹16.36 Cr -₹1.72 Cr ₹12 Cr -₹3.9 Cr
Capital Expenditure -₹1.27 Cr ₹3.58 Cr ₹13.09 Cr -₹13.53 Cr ₹17.15 Cr
Free Cash Flow (computed) ₹2.91 Cr -₹8.95 Cr ₹1.95 Cr -₹38.41 Cr ₹3.43 Cr
Dividends Paid ₹0 ₹0 ₹0 -₹40 Lakh ₹80 Lakh
Net Change in Cash -₹5.99 Cr ₹5.82 Cr ₹27.34 Lakh ₹82.88 Lakh -₹1.01 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹48.75 Cr ₹42.59 Cr ₹51 Cr ₹53.81 Cr ₹40.93 Cr ₹42.05 Cr ₹44.05 Cr ₹32.45 Cr
Other Income ₹15.95 Lakh ₹24.8 Lakh ₹28.93 Lakh ₹54.96 Lakh ₹21.62 Lakh ₹47,000 ₹14.08 Lakh ₹32.53 Lakh
Total Income ₹48.91 Cr ₹42.84 Cr ₹51.29 Cr ₹54.36 Cr ₹41.15 Cr ₹42.06 Cr ₹44.19 Cr ₹32.77 Cr
Cost of Materials Consumed ₹33.04 Cr ₹27.33 Cr ₹29.55 Cr ₹35.4 Cr ₹22.37 Cr ₹24.44 Cr ₹27.1 Cr ₹23.59 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹5.61 Cr -₹1.22 Cr ₹3.22 Cr ₹1.66 Cr ₹2.52 Cr ₹90.23 Lakh -₹1.03 Cr -₹1.35 Cr
Employee Benefit Expense ₹3.82 Cr ₹3.9 Cr ₹3.81 Cr ₹3.96 Cr ₹4.27 Cr ₹3.33 Cr ₹4.35 Cr ₹4.4 Cr
Finance Costs ₹2.76 Cr ₹1.23 Cr ₹1.23 Cr ₹1.31 Cr ₹1.15 Cr ₹1.4 Cr ₹1.35 Cr ₹1.29 Cr
Depreciation & Amortisation ₹1.93 Cr ₹1.52 Cr ₹1.52 Cr ₹1.52 Cr ₹1.56 Cr ₹1.47 Cr ₹1.47 Cr ₹1.47 Cr
Other Expenses ₹10.8 Cr ₹9.04 Cr ₹9.29 Cr ₹8.37 Cr ₹8.34 Cr ₹9.36 Cr ₹10.2 Cr ₹9.46 Cr
Total Expenses ₹46.74 Cr ₹41.8 Cr ₹48.62 Cr ₹52.2 Cr ₹40.2 Cr ₹40.91 Cr ₹43.44 Cr ₹38.86 Cr
Profit Before Exceptional Items & Tax ₹2.17 Cr ₹1.04 Cr ₹2.67 Cr ₹2.16 Cr ₹94.87 Lakh ₹1.15 Cr ₹74.71 Lakh -₹6.09 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹2.17 Cr ₹1.04 Cr ₹2.67 Cr ₹2.16 Cr ₹94.87 Lakh ₹1.15 Cr ₹74.71 Lakh -₹6.09 Cr
Total Tax Expense -₹45.78 Lakh ₹68.1 Lakh ₹1.52 Cr ₹75.92 Lakh -₹1.96 Cr ₹1.04 Lakh ₹69,000 ₹9,000
Net Profit ₹2.63 Cr ₹35.63 Lakh ₹1.16 Cr ₹1.41 Cr ₹2.91 Cr ₹1.14 Cr ₹74.02 Lakh -₹6.09 Cr
Other Comprehensive Income -₹1.52 Lakh ₹0 ₹0 ₹0 -₹1.6 Cr ₹0 ₹0 ₹0
Total Comprehensive Income ₹2.61 Cr ₹35.63 Lakh ₹1.16 Cr ₹1.41 Cr ₹1.31 Cr ₹1.14 Cr ₹74.02 Lakh -₹6.09 Cr
EBITDA (computed) ₹6.86 Cr ₹3.79 Cr ₹5.42 Cr ₹4.99 Cr ₹3.65 Cr ₹4.02 Cr ₹3.57 Cr -₹3.33 Cr
Basic EPS ₹2.69 ₹0.99 ₹1.19 ₹1.45 ₹1.35 ₹1.42 ₹0.93 ₹-7.61
Diluted EPS ₹2.69 ₹0.99 ₹1.19 ₹1.45 ₹1.35 ₹1.42 ₹0.93 ₹-7.61
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Everest Organics Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Everest Organics Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 59.58%, domestic institutional investors hold 0.02%, retail and other public shareholders hold 40.40% of Everest Organics Limited. The company had 7,880 shareholders on record.

Promoters: 59.58%DII (Domestic Institutional): 0.02%Retail & Others: 40.40%
Mar 2026
QUARTER
59.58% Promoters
0.02% DII (Domestic Institutional)
40.40% Retail & Others
Promoter holding - history
Now 59.58% · Mar 2026High 74.15% · Jun 2023Low 59.58% · Mar 2026
58%62.5%67%71.5%76%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 74.15%Sep 2023: 74.15%Dec 2023: 74.15%Mar 2024: 74.15%Jun 2024: 74.15%Sep 2024: 74.15%Dec 2024: 74.15%Mar 2025: 61.09%Jun 2025: 60.99%Sep 2025: 59.64%Dec 2025: 59.61%Mar 2026: 59.58%74.15%59.58%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters59.58%59.61%59.64%60.99%61.09%74.15%
Public40.42%40.39%40.36%39.01%38.91%25.85%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters59.58%61.09%74.15%
Public40.42%38.91%25.85%
Promoter change (YoY, %pts)-1.51-13.06-

Charges & Borrowings of Everest Organics Limited

Open charges
₹73.38 Cr
Satisfied charges
₹118.08 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹57.34 Cr
Canara Bank₹15.00 Cr
Axis Bank Limited₹0.88 Cr
Others₹0.17 Cr
Latest charge details
DateLenderAmountStatus
08 Mar 2023 Canara Bank ₹15 Cr Open
18 May 2022 Others ₹16.75 Lakh Open
31 Mar 2021 Axis Bank Limited ₹64.16 Lakh Open
28 Dec 2020 Hdfc Bank Limited ₹57.34 Cr Open
18 Mar 2020 Axis Bank Limited ₹23.7 Lakh Open

Total charge records: 30 View all charges

Employees and EPFO Compliance at Everest Organics Limited

Everest Organics Limited has a workforce of 387 employees as of Jan 26, 2025.

Employee count
387
Active EPFO establishments
1
Employee growth
-2.03%
Premium access

Employee and EPFO history for Everest Organics Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Everest Organics Limited

Premium access

GST registrations and filing compliance for Everest Organics Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Everest Organics Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Everest Organics Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Everest Organics Limited

Premium access

MSME payment history for Everest Organics Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Everest Organics Limited

Premium access

Corporate group structure for Everest Organics Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Everest Organics Limited

Premium access

MCA filings and documents for Everest Organics Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Everest Organics Limited

Activity
27 Sep 2025
Everest Organics Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Directors
05 Sep 2025
Shweta Singh was appointed as a Company Secretary on 05 Sep 2025 & has been associated with this company since 10 months 7 days.
Activity
31 Mar 2025
Everest Organics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
13 Jan 2025
Kirankumar Rampally was appointed as a Director on 13 Jan 2025 & has been associated with this company since 1 year 6 months.
Directors
13 Nov 2024
Venkata Satyanarayana Murthy Vadali was appointed as a Director on 13 Nov 2024 & has been associated with this company since 1 year 7 months.
Charges
31 Jan 2024
A charge with Hdfc Bank Limited of Rs. 57.34 Cr registered on 28 Dec 2020 with Charge ID 100443191 was modified on 31 Jan 2024.

Recent News on Everest Organics Limited

Everest Organics enters US market
23 Nov 2017 · Business Medical Dialogues

Frequently Asked Questions about Everest Organics Limited

Everest Organics Limited is an active public limited company in the pharma sector based in Medak, Telangana, India. It was incorporated on 19 February 1993 (33+ years old) and is registered under CIN L24230TG1993PLC015426. Listed on BSE: 524790. The company has 387 employees.

Everest Organics Limited reported revenue of ₹196.16 Cr for FY 2026 (up 23% YoY) based on standalone BSE filings.

The current directors of Everest Organics Limited are:

The primary industry of Everest Organics Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Everest Organics Limited is listed on BSE with code 524790.

Everest Organics Limited can be reached at the registered office: Aroor Village Sadasivapet Mandal Medak, Telangana, India – 502291, or through the website everestorganicsltd.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available